After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

Needham has downgraded Biogen (BIIB) to hold from buy, citing a lack of near-term catalysts and slow uptake for the company’s ...

This valuation suggests that the market may be underestimating Biogen's potential, particularly if the company can achieve sales inflections or positive pipeline developments. Biogen's product ...

This valuation suggests that the market may be underestimating Biogen's potential, particularly if the company can achieve sales inflections or positive pipeline developments. Biogen's product ...

Enbridge Inc. ENB-T has begun talks with its customers about expanding its Mainline pipeline network to handle growing volumes of Canadian oil output, the Calgary-based company said Friday.

Biogen may not be an investment for everyone, and its product portfolio and pipeline may be imperfect in multiple ways, but the potential adds up to substantially more than a $25bn market cap ...

Customers for the project include Autodesk, Inc., Biogen Inc., EMD Electronics (the U.S. and Canada ... and battery energy storage projects with a geographically diversified pipeline in various stages ...